Covid-19 Impact on Global Opioids Drug Industry Research Report 2020 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2026

Covid-19 Impact on Global Opioids Drug Industry Research Report 2020 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2026

Table of Contents

1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Opioids Drug Revenue
1.5 Market Analysis by Type
1.5.1 Global Opioids Drug Market Size Growth Rate by Type: 2020 VS 2026
1.5.2 Oxycodone
1.5.3 Hydromorphone
1.5.4 Codeine
1.5.5 Fentanyl
1.5.6 Other
1.6 Market by Application
1.6.1 Global Opioids Drug Market Share by Application: 2021-2026
1.6.2 Pain Relief
1.6.3 Anesthesia
1.6.4 Other
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Opioids Drug Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter's Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Opioids Drug Market Players Profiles
3.1 Teva
3.1.1 Teva Company Profile
3.1.2 Teva Opioids Drug Product Specification
3.1.3 Teva Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.2 Pfizer
3.2.1 Pfizer Company Profile
3.2.2 Pfizer Opioids Drug Product Specification
3.2.3 Pfizer Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.3 Amneal Pharma
3.3.1 Amneal Pharma Company Profile
3.3.2 Amneal Pharma Opioids Drug Product Specification
3.3.3 Amneal Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 Purdue Pharma
3.4.1 Purdue Pharma Company Profile
3.4.2 Purdue Pharma Opioids Drug Product Specification
3.4.3 Purdue Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Endo
3.5.1 Endo Company Profile
3.5.2 Endo Opioids Drug Product Specification
3.5.3 Endo Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 Mallinckrodt
3.6.1 Mallinckrodt Company Profile
3.6.2 Mallinckrodt Opioids Drug Product Specification
3.6.3 Mallinckrodt Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Mylan
3.7.1 Mylan Company Profile
3.7.2 Mylan Opioids Drug Product Specification
3.7.3 Mylan Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 J&J
3.8.1 J&J Company Profile
3.8.2 J&J Opioids Drug Product Specification
3.8.3 J&J Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Collegium
3.9.1 Collegium Company Profile
3.9.2 Collegium Opioids Drug Product Specification
3.9.3 Collegium Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 INSYS
3.10.1 INSYS Company Profile
3.10.2 INSYS Opioids Drug Product Specification
3.10.3 INSYS Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 Hikma
3.11.1 Hikma Company Profile
3.11.2 Hikma Opioids Drug Product Specification
3.11.3 Hikma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Egalet
3.12.1 Egalet Company Profile
3.12.2 Egalet Opioids Drug Product Specification
3.12.3 Egalet Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Opioids Drug Market Competition by Market Players
4.1 Global Opioids Drug Production Capacity Market Share by Market Players (2015-2020)
4.2 Global Opioids Drug Revenue Market Share by Market Players (2015-2020)
4.3 Global Opioids Drug Average Price by Market Players (2015-2020)
5 Global Opioids Drug Production by Regions (2015-2020)
5.1 North America
5.1.1 North America Opioids Drug Market Size (2015-2020)
5.1.2 Opioids Drug Key Players in North America (2015-2020)
5.1.3 North America Opioids Drug Market Size by Type (2015-2020)
5.1.4 North America Opioids Drug Market Size by Application (2015-2020)
5.2 East Asia
5.2.1 East Asia Opioids Drug Market Size (2015-2020)
5.2.2 Opioids Drug Key Players in East Asia (2015-2020)
5.2.3 East Asia Opioids Drug Market Size by Type (2015-2020)
5.2.4 East Asia Opioids Drug Market Size by Application (2015-2020)
5.3 Europe
5.3.1 Europe Opioids Drug Market Size (2015-2020)
5.3.2 Opioids Drug Key Players in Europe (2015-2020)
5.3.3 Europe Opioids Drug Market Size by Type (2015-2020)
5.3.4 Europe Opioids Drug Market Size by Application (2015-2020)
5.4 South Asia
5.4.1 South Asia Opioids Drug Market Size (2015-2020)
5.4.2 Opioids Drug Key Players in South Asia (2015-2020)
5.4.3 South Asia Opioids Drug Market Size by Type (2015-2020)
5.4.4 South Asia Opioids Drug Market Size by Application (2015-2020)
5.5 Southeast Asia
5.5.1 Southeast Asia Opioids Drug Market Size (2015-2020)
5.5.2 Opioids Drug Key Players in Southeast Asia (2015-2020)
5.5.3 Southeast Asia Opioids Drug Market Size by Type (2015-2020)
5.5.4 Southeast Asia Opioids Drug Market Size by Application (2015-2020)
5.6 Middle East
5.6.1 Middle East Opioids Drug Market Size (2015-2020)
5.6.2 Opioids Drug Key Players in Middle East (2015-2020)
5.6.3 Middle East Opioids Drug Market Size by Type (2015-2020)
5.6.4 Middle East Opioids Drug Market Size by Application (2015-2020)
5.7 Africa
5.7.1 Africa Opioids Drug Market Size (2015-2020)
5.7.2 Opioids Drug Key Players in Africa (2015-2020)
5.7.3 Africa Opioids Drug Market Size by Type (2015-2020)
5.7.4 Africa Opioids Drug Market Size by Application (2015-2020)
5.8 Oceania
5.8.1 Oceania Opioids Drug Market Size (2015-2020)
5.8.2 Opioids Drug Key Players in Oceania (2015-2020)
5.8.3 Oceania Opioids Drug Market Size by Type (2015-2020)
5.8.4 Oceania Opioids Drug Market Size by Application (2015-2020)
5.9 South America
5.9.1 South America Opioids Drug Market Size (2015-2020)
5.9.2 Opioids Drug Key Players in South America (2015-2020)
5.9.3 South America Opioids Drug Market Size by Type (2015-2020)
5.9.4 South America Opioids Drug Market Size by Application (2015-2020)
5.10 Rest of the World
5.10.1 Rest of the World Opioids Drug Market Size (2015-2020)
5.10.2 Opioids Drug Key Players in Rest of the World (2015-2020)
5.10.3 Rest of the World Opioids Drug Market Size by Type (2015-2020)
5.10.4 Rest of the World Opioids Drug Market Size by Application (2015-2020)
6 Global Opioids Drug Consumption by Region (2015-2020)
6.1 North America
6.1.1 North America Opioids Drug Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Opioids Drug Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Opioids Drug Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Opioids Drug Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Opioids Drug Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Opioids Drug Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Opioids Drug Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Opioids Drug Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Opioids Drug Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Opioids Drug Consumption by Countries
7 Global Opioids Drug Production Forecast by Regions (2021-2026)
7.1 Global Forecasted Production of Opioids Drug (2021-2026)
7.2 Global Forecasted Revenue of Opioids Drug (2021-2026)
7.3 Global Forecasted Price of Opioids Drug (2021-2026)
7.4 Global Forecasted Production of Opioids Drug by Region (2021-2026)
7.4.1 North America Opioids Drug Production, Revenue Forecast (2021-2026)
7.4.2 East Asia Opioids Drug Production, Revenue Forecast (2021-2026)
7.4.3 Europe Opioids Drug Production, Revenue Forecast (2021-2026)
7.4.4 South Asia Opioids Drug Production, Revenue Forecast (2021-2026)
7.4.5 Southeast Asia Opioids Drug Production, Revenue Forecast (2021-2026)
7.4.6 Middle East Opioids Drug Production, Revenue Forecast (2021-2026)
7.4.7 Africa Opioids Drug Production, Revenue Forecast (2021-2026)
7.4.8 Oceania Opioids Drug Production, Revenue Forecast (2021-2026)
7.4.9 South America Opioids Drug Production, Revenue Forecast (2021-2026)
7.4.10 Rest of the World Opioids Drug Production, Revenue Forecast (2021-2026)
7.5 Forecast by Type and by Application (2021-2026)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
7.5.2 Global Forecasted Consumption of Opioids Drug by Application (2021-2026)
8 Global Opioids Drug Consumption Forecast by Regions (2021-2026)
8.1 North America Forecasted Consumption of Opioids Drug by Country
8.2 East Asia Market Forecasted Consumption of Opioids Drug by Country
8.3 Europe Market Forecasted Consumption of Opioids Drug by Countriy
8.4 South Asia Forecasted Consumption of Opioids Drug by Country
8.5 Southeast Asia Forecasted Consumption of Opioids Drug by Country
8.6 Middle East Forecasted Consumption of Opioids Drug by Country
8.7 Africa Forecasted Consumption of Opioids Drug by Country
8.8 Oceania Forecasted Consumption of Opioids Drug by Country
8.9 South America Forecasted Consumption of Opioids Drug by Country
8.10 Rest of the world Forecasted Consumption of Opioids Drug by Country
9 Global Opioids Drug Sales by Type (2015-2026)
9.1 Global Opioids Drug Historic Market Size by Type (2015-2020)
9.2 Global Opioids Drug Forecasted Market Size by Type (2021-2026)
10 Global Opioids Drug Consumption by Application (2015-2026)
10.1 Global Opioids Drug Historic Market Size by Application (2015-2020)
10.2 Global Opioids Drug Forecasted Market Size by Application (2021-2026)
11 Global Opioids Drug Manufacturing Cost Analysis
11.1 Opioids Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Opioids Drug
12 Global Opioids Drug Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Opioids Drug Distributors List
12.3 Opioids Drug Customers
12.4 Opioids Drug Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer


Table 1. Research Programs/Design for This Report
Table 2. Key Data Information from Secondary Sources
Table 3. Key Executives Interviewed
Table 4. Key Data Information from Primary Sources
Table 5. Key Players Covered: Ranking by Opioids Drug Revenue (US$ Million) 2015-2020
Table 6. Global Opioids Drug Market Size by Type (US$ Million): 2021-2026
Table 7. Oxycodone Features
Table 8. Hydromorphone Features
Table 9. Codeine Features
Table 10. Fentanyl Features
Table 11. Other Features
Table 16. Global Opioids Drug Market Size by Application (US$ Million): 2021-2026
Table 17. Pain Relief Case Studies
Table 18. Anesthesia Case Studies
Table 19. Other Case Studies
Table 26. Overview of the World Economic Outlook Projections
Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 32. Commodity Prices-Metals Price Indices
Table 33. Commodity Prices- Precious Metal Price Indices
Table 34. Commodity Prices- Agricultural Raw Material Price Indices
Table 35. Commodity Prices- Food and Beverage Price Indices
Table 36. Commodity Prices- Fertilizer Price Indices
Table 37. Commodity Prices- Energy Price Indices
Table 38. G20+: Economic Policy Responses to COVID-19
Table 39. Covid-19 Impact: Global Major Government Policy
Table 40. Opioids Drug Report Years Considered
Table 41. Market Top Trends
Table 42. Key Drivers: Impact Analysis
Table 43. Key Challenges
Table 44. Porter's Five Forces Analysis
Table 45. Opioids Drug Market Growth Strategy
Table 46. Opioids Drug SWOT Analysis
Table 47. Teva Opioids Drug Product Specification
Table 48. Teva Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 49. Pfizer Opioids Drug Product Specification
Table 50. Pfizer Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 51. Amneal Pharma Opioids Drug Product Specification
Table 52. Amneal Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 53. Purdue Pharma Opioids Drug Product Specification
Table 54. Table Purdue Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 55. Endo Opioids Drug Product Specification
Table 56. Endo Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 57. Mallinckrodt Opioids Drug Product Specification
Table 58. Mallinckrodt Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 59. Mylan Opioids Drug Product Specification
Table 60. Mylan Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 61. J&J Opioids Drug Product Specification
Table 62. J&J Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 63. Collegium Opioids Drug Product Specification
Table 64. Collegium Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 65. INSYS Opioids Drug Product Specification
Table 66. INSYS Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 67. Hikma Opioids Drug Product Specification
Table 68. Hikma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 69. Egalet Opioids Drug Product Specification
Table 70. Egalet Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 147. Global Opioids Drug Production Capacity by Market Players
Table 148. Global Opioids Drug Production by Market Players (2015-2020)
Table 149. Global Opioids Drug Production Market Share by Market Players (2015-2020)
Table 150. Global Opioids Drug Revenue by Market Players (2015-2020)
Table 151. Global Opioids Drug Revenue Share by Market Players (2015-2020)
Table 152. Global Market Opioids Drug Average Price of Key Market Players (2015-2020)
Table 153. North America Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 154. North America Key Players Opioids Drug Market Share (2015-2020)
Table 155. North America Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 156. North America Opioids Drug Market Share by Type (2015-2020)
Table 157. North America Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 158. North America Opioids Drug Market Share by Application (2015-2020)
Table 159. East Asia Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 160. East Asia Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 161. East Asia Key Players Opioids Drug Market Share (2015-2020)
Table 162. East Asia Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 163. East Asia Opioids Drug Market Share by Type (2015-2020)
Table 164. East Asia Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 165. East Asia Opioids Drug Market Share by Application (2015-2020)
Table 166. Europe Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 167. Europe Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 168. Europe Key Players Opioids Drug Market Share (2015-2020)
Table 169. Europe Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 170. Europe Opioids Drug Market Share by Type (2015-2020)
Table 171. Europe Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 172. Europe Opioids Drug Market Share by Application (2015-2020)
Table 173. South Asia Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 174. South Asia Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 175. South Asia Key Players Opioids Drug Market Share (2015-2020)
Table 176. South Asia Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 177. South Asia Opioids Drug Market Share by Type (2015-2020)
Table 178. South Asia Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 179. South Asia Opioids Drug Market Share by Application (2015-2020)
Table 180. Southeast Asia Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 181. Southeast Asia Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 182. Southeast Asia Key Players Opioids Drug Market Share (2015-2020)
Table 183. Southeast Asia Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 184. Southeast Asia Opioids Drug Market Share by Type (2015-2020)
Table 185. Southeast Asia Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 186. Southeast Asia Opioids Drug Market Share by Application (2015-2020)
Table 187. Middle East Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 188. Middle East Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 189. Middle East Key Players Opioids Drug Market Share (2015-2020)
Table 190. Middle East Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 191. Middle East Opioids Drug Market Share by Type (2015-2020)
Table 192. Middle East Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 193. Middle East Opioids Drug Market Share by Application (2015-2020)
Table 194. Africa Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 195. Africa Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 196. Africa Key Players Opioids Drug Market Share (2015-2020)
Table 197. Africa Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 198. Africa Opioids Drug Market Share by Type (2015-2020)
Table 199. Africa Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 200. Africa Opioids Drug Market Share by Application (2015-2020)
Table 201. Oceania Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 202. Oceania Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 203. Oceania Key Players Opioids Drug Market Share (2015-2020)
Table 204. Oceania Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 205. Oceania Opioids Drug Market Share by Type (2015-2020)
Table 206. Oceania Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 207. Oceania Opioids Drug Market Share by Application (2015-2020)
Table 208. South America Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 209. South America Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 210. South America Key Players Opioids Drug Market Share (2015-2020)
Table 211. South America Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 212. South America Opioids Drug Market Share by Type (2015-2020)
Table 213. South America Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 214. South America Opioids Drug Market Share by Application (2015-2020)
Table 215. Rest of the World Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 216. Rest of the World Key Players Opioids Drug Revenue (2015-2020) (US$ Million)
Table 217. Rest of the World Key Players Opioids Drug Market Share (2015-2020)
Table 218. Rest of the World Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 219. Rest of the World Opioids Drug Market Share by Type (2015-2020)
Table 220. Rest of the World Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 221. Rest of the World Opioids Drug Market Share by Application (2015-2020)
Table 222. North America Opioids Drug Consumption by Countries (2015-2020)
Table 223. East Asia Opioids Drug Consumption by Countries (2015-2020)
Table 224. Europe Opioids Drug Consumption by Region (2015-2020)
Table 225. South Asia Opioids Drug Consumption by Countries (2015-2020)
Table 226. Southeast Asia Opioids Drug Consumption by Countries (2015-2020)
Table 227. Middle East Opioids Drug Consumption by Countries (2015-2020)
Table 228. Africa Opioids Drug Consumption by Countries (2015-2020)
Table 229. Oceania Opioids Drug Consumption by Countries (2015-2020)
Table 230. South America Opioids Drug Consumption by Countries (2015-2020)
Table 231. Rest of the World Opioids Drug Consumption by Countries (2015-2020)
Table 232. Global Opioids Drug Production Forecast by Region (2021-2026)
Table 233. Global Opioids Drug Sales Volume Forecast by Type (2021-2026)
Table 234. Global Opioids Drug Sales Volume Market Share Forecast by Type (2021-2026)
Table 235. Global Opioids Drug Sales Revenue Forecast by Type (2021-2026)
Table 236. Global Opioids Drug Sales Revenue Market Share Forecast by Type (2021-2026)
Table 237. Global Opioids Drug Sales Price Forecast by Type (2021-2026)
Table 238. Global Opioids Drug Consumption Volume Forecast by Application (2021-2026)
Table 239. Global Opioids Drug Consumption Value Forecast by Application (2021-2026)
Table 240. North America Opioids Drug Consumption Forecast 2021-2026 by Country
Table 241. East Asia Opioids Drug Consumption Forecast 2021-2026 by Country
Table 242. Europe Opioids Drug Consumption Forecast 2021-2026 by Country
Table 243. South Asia Opioids Drug Consumption Forecast 2021-2026 by Country
Table 244. Southeast Asia Opioids Drug Consumption Forecast 2021-2026 by Country
Table 245. Middle East Opioids Drug Consumption Forecast 2021-2026 by Country
Table 246. Africa Opioids Drug Consumption Forecast 2021-2026 by Country
Table 247. Oceania Opioids Drug Consumption Forecast 2021-2026 by Country
Table 248. South America Opioids Drug Consumption Forecast 2021-2026 by Country
Table 249. Rest of the world Opioids Drug Consumption Forecast 2021-2026 by Country
Table 250. Global Opioids Drug Market Size by Type (2015-2020) (US$ Million)
Table 251. Global Opioids Drug Revenue Market Share by Type (2015-2020)
Table 252. Global Opioids Drug Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 253. Global Opioids Drug Revenue Market Share by Type (2021-2026)
Table 254. Global Opioids Drug Market Size by Application (2015-2020) (US$ Million)
Table 255. Global Opioids Drug Revenue Market Share by Application (2015-2020)
Table 256. Global Opioids Drug Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 257. Global Opioids Drug Revenue Market Share by Application (2021-2026)
Table 258. Opioids Drug Distributors List
Table 259. Opioids Drug Customers List


Figure 1. Product Figure
Figure 2. Global Opioids Drug Market Share by Type: 2020 VS 2026
Figure 3. Global Opioids Drug Market Share by Application: 2020 VS 2026
Figure 4. North America Opioids Drug Market Size YoY Growth (2015-2020) (US$ Million)
Figure 5. North America Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 6. North America Opioids Drug Consumption Market Share by Countries in 2020
Figure 7. United States Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 8. Canada Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 9. Mexico Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 10. East Asia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 11. East Asia Opioids Drug Consumption Market Share by Countries in 2020
Figure 12. China Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 13. Japan Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 14. South Korea Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 15. Europe Opioids Drug Consumption and Growth Rate
Figure 16. Europe Opioids Drug Consumption Market Share by Region in 2020
Figure 17. Germany Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 18. United Kingdom Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 19. France Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 20. Italy Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 21. Russia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 22. Spain Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 23. Netherlands Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 24. Switzerland Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 25. Poland Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 26. South Asia Opioids Drug Consumption and Growth Rate
Figure 27. South Asia Opioids Drug Consumption Market Share by Countries in 2020
Figure 28. India Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 29. Southeast Asia Opioids Drug Consumption and Growth Rate
Figure 30. Southeast Asia Opioids Drug Consumption Market Share by Countries in 2020
Figure 31. Indonesia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 32. Thailand Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 33. Singapore Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 34. Malaysia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 35. Philippines Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Opioids Drug Consumption and Growth Rate
Figure 37. Middle East Opioids Drug Consumption Market Share by Countries in 2020
Figure 38. Turkey Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 40. Iran Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 42. Africa Opioids Drug Consumption and Growth Rate
Figure 43. Africa Opioids Drug Consumption Market Share by Countries in 2020
Figure 44. Nigeria Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 45. South Africa Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 46. Oceania Opioids Drug Consumption and Growth Rate
Figure 47. Oceania Opioids Drug Consumption Market Share by Countries in 2020
Figure 48. Australia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 49. South America Opioids Drug Consumption and Growth Rate
Figure 50. South America Opioids Drug Consumption Market Share by Countries in 2020
Figure 51. Brazil Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 52. Argentina Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 53. Rest of the World Opioids Drug Consumption and Growth Rate
Figure 54. Rest of the World Opioids Drug Consumption Market Share by Countries in 2020
Figure 55. Global Opioids Drug Production Capacity Growth Rate Forecast (2021-2026)
Figure 56. Global Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 57. Global Opioids Drug Price and Trend Forecast (2021-2026)
Figure 58. North America Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 59. North America Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 60. East Asia Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 61. East Asia Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 62. Europe Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 63. Europe Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 64. South Asia Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 65. South Asia Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 66. Southeast Asia Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 67. Southeast Asia Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 68. Middle East Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 69. Middle East Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 70. Africa Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 71. Africa Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 72. Oceania Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 73. Oceania Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 74. South America Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 75. South America Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 76. Rest of the World Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 77. Rest of the World Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 78. North America Opioids Drug Consumption Forecast 2021-2026
Figure 79. East Asia Opioids Drug Consumption Forecast 2021-2026
Figure 80. Europe Opioids Drug Consumption Forecast 2021-2026
Figure 81. South Asia Opioids Drug Consumption Forecast 2021-2026
Figure 82. Southeast Asia Opioids Drug Consumption Forecast 2021-2026
Figure 83. Middle East Opioids Drug Consumption Forecast 2021-2026
Figure 84. Africa Opioids Drug Consumption Forecast 2021-2026
Figure 85. Oceania Opioids Drug Consumption Forecast 2021-2026
Figure 86. South America Opioids Drug Consumption Forecast 2021-2026
Figure 87. Rest of the world Opioids Drug Consumption Forecast 2021-2026
Figure 88. Manufacturing Cost Structure of Opioids Drug
Figure 89. Manufacturing Process Analysis of Opioids Drug
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Opioids Drug Supply Chain Analysis

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs